ACST
|Acasti Pharma Inc
NASDAQ
USD
|%
Current Price
Change
(%)
P/E Ratio
Dividend Yield
Market Cap
34.17M
Volume
Open
Previous Close
52-Week High
USD 3.60
52-Week Low
USD 2.13
About Acasti Pharma Inc
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma ...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Prashant Kohli
Employees:
Headquarters:Princeton, USA
Website:www.acastipharma.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions